Nav: Home

Stopping Zika from crossing the placenta

April 04, 2017

SAN FRANCISCO, April 4, 2017 -- Although the World Health Organization ended its global health emergency on Zika last November, the virus could still make a comeback as temperatures get warmer and mosquito season ramps up. Over 5,000 cases have been identified in the U.S. over the past two years, including about 1,500 pregnant women, and 70 countries have reported evidence of Zika transmission. It is a particularly insidious virus because it can cross the placenta and cause birth defects. Now, researchers may have figured out how this virus invades the placenta, and they are taking steps to develop strategies that block its access.

The researchers will present their work today at the 253rd National Meeting & Exposition of the American Chemical Society (ACS). ACS, the world's largest scientific society, is holding the meeting here through Thursday. It features more than 14,000 presentations on a wide range of science topics.

"We worked on the dengue virus 20 years ago, and when Zika popped up in the news, we knew immediately that the two mosquito-borne viruses were related members of the flavivirus family," Robert Linhardt, Ph.D., says. In his team's previous work, the researchers discovered that the dengue virus could get into cells by binding to sugars. "Based on the similarity between the two viruses, we thought that maybe Zika did the same thing," he explains.

The Zika virus has a coating consisting of many copies of an envelope protein. This protein binds to particular targets on the surfaces of host cells, ushering the virus inside to replicate. To figure out the identities of the host-cell targets, Linhardt's team, led by graduate student So Young Kim at the Rensselaer Polytechnic Institute, mixed the envelope protein with sugars called glycosaminoglycans, which the dengue virus uses for this purpose.

"With a technique called surface plasmon resonance, we can monitor binding interactions in real time," Kim says. "We started with the sugar heparin, which is highly negatively charged, and saw very tight binding with the Zika envelope protein. This suggested that the binding was largely based on electrostatic interactions, as observed in dengue virus." In further experiments, the protein appeared to also have some sequence preferences.

As a next step, the researchers extracted sugars from human tissues -- adult brain and placenta -- and tested whether and how tightly the Zika envelope protein bound. They identified a particular placental sugar, chondroitin sulfate, which seemed to bind tightly to the virus, and this molecule may be the Zika virus' ticket into the placenta. The interaction between the envelope protein and sugars from porcine adult brain was weaker. "Adult brain is probably not the best tissue to model," Linhardt says, because the Zika virus is known to be particularly damaging to the fetus. "We are developing a fetal brain stem cell line to identify other fetal brain sugars that may be targets of Zika," he adds. To further validate the approach, the researchers are also collaborating with another group to study binding between sugars and live Zika virus.

In addition to answering basic questions about how Zika invades cells, Linhardt's group also wants to come up with a way to block the interactions between the virus and placental sugars, protecting the fetus from harm. In earlier work, the researchers developed a virus-killing nanoparticle coated in the sugar that the influenza virus uses to invade lung tissue. Giving the nanoparticle to mice prevented them from getting sick. The researchers are working on a similar approach with the Zika virus.

The researchers are feeling a particular urgency to make advances as soon as possible. "We think Zika is going to come back with a vengeance this summer," Linhardt says. "That's why we are working really hard to understand Zika as best as we can, as fast as we can."
A press conference on this topic will be held Tuesday, April 4, at 10:30 a.m. Pacific time in the Moscone Center. Reporters may check-in at the press center, South Building, Foyer, or watch live on YouTube To ask questions online, sign in with a Google account.

Linhardt acknowledges funding from the U.S. National Institutes of Health for funding his work on glycosaminoglycans.

The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With nearly 157,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. ACS does not conduct research, but publishes and publicizes peer-reviewed scientific studies. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive press releases from the American Chemical Society, contact

Note to journalists: Please report that this research was presented at a meeting of the American Chemical Society.

Follow us: Twitter | Facebook


Host cell entry of Zika virus may be mediated by glycosaminoglycans


Zika Virus (ZIKV)'s ability to cause severe fetal anomalies led academic, federal, and industry research groups put urgent efforts to tackle ZIKV from basic, detection, and therapeutics research perspectives. While we are filling in the pieces of the whole picture of ZIKV, pathogenesis of related pathogenic flaviviruses has been well understood. Various pathogenic flaviviruses attach to glycosaminoglycans (GAGs) through their envelop protein and concentrate themselves on the surface of host cells as a first step in the process of pathogenesis. In this study, we utilized surface plasmon resonance (SPR) to screen various GAGs for their binding to envelope protein of ZIKV (ZIKV E). ZIKV E binds most strongly to heparin (HP), a most highly sulfated GAG, suggesting that the ZIKV E-GAG interaction is mainly electrostatically interaction driven as seen in other pathogenic flaviviruses. However, the order in which ZIKV E binds to various GAGs is not completely dependent upon the degree of sulfation showing that ZIKV E has specific saccharide sequence it prefers binding to. We also found that ZIKV E preferentially binds to longer chain HP oligosaccharides (8-18 saccharides) using SPR competition assays. Next, we isolated GAGs from human placentas and tested their binding to ZIKV E potentially mediating ZIKV to invade placenta prior to fetal infection. Both placental chondroitin sulfate and heparan sulfate GAGs showed micromolar interactions with ZIKV E. Finally we determined ZIKV E binding to porcine brain CS and HS, which showed relatively micromolar binding with ZIKV E. These results advance our understanding of ZIKV's pathogenesis and facilitate to develop therapeutics to effectively combat ZIKV with more insight.

American Chemical Society

Related Birth Defects Articles:

Weight-loss surgery cuts risk of birth defects
Children born to women who underwent gastric bypass surgery before becoming pregnant had a lower risk of major birth defects than children born to women who had severe obesity at the start of their pregnancy.
Defective cilia linked to heart valve birth defects
Bicuspid aortic valve (BAV), the most common heart valve birth defect, is associated with genetic variation in human primary cilia during heart valve development, report Medical University of South Carolina researchers in Circulation.
Findings shed new light on why Zika causes birth defects in some pregnancies
A new study shows that the risk of giving birth to a child with microcephaly might be related to how the immune system reacts against the Zika virus -- specifically what kind of antibodies it produces.
Study reveals elevated cancer risk in children with birth defects
A collaborative team of scientists led by Baylor College of Medicine has assembled the largest study to date to evaluate cancer risk in children with birth defects.
Severe air pollution can cause birth defects, deaths
In a comprehensive study, researchers from Texas A&M University have determined that harmful particulate matter in the atmosphere can produce birth defects and even fatalities during pregnancy using the animal model.
Famous cancer-fighting gene also protects against birth defects
New research has revealed how the famous tumour suppressor gene p53 is surprisingly critical for development of the neural tube in female embryos.
Biomarkers may predict Zika-related birth defects
The highest risk of birth defects is from Zika virus infection during the first and second trimester.
After 60 years, scientists uncover how thalidomide produced birth defects
More than 60 years after the drug thalidomide caused birth defects in thousands of children whose mothers took the drug while pregnant, scientists at Dana-Farber Cancer Institute have solved a mystery that has lingered ever since the dangers of the drug first became apparent: how did the drug produce such severe fetal harm?
Antiepileptic drug induces birth defects in frogs
A common drug for treating epileptic seizures may lead to birth defects if used during pregnancy by interfering with glutamate signaling in earliest stages of nervous system development, finds a study in frogs published in JNeurosci.
All in the family: Relatives of Zika virus may cause birth defects
Relatives of Zika virus can damage developing fetuses in mice and were able to replicate in human maternal and fetal tissues, researchers report.
More Birth Defects News and Birth Defects Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.